Do analysts rate BLCO or UFPT?

Bausch + Lomb currently has a consensus price target of $18.75, indicating a potential upside of 8.70%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, equities analysts clearly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.31 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor MMSI or UFPT?

In the previous week, UFP Technologies had 3 more articles in the media than Merit Medical Systems. MarketBeat recorded 13 mentions for UFP Technologies and 10 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.99 beat UFP Technologies' score of 0.78 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate UFPT or ICUI?

ICU Medical has a consensus price target of $192.80, suggesting a potential upside of 5.45%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89

Does the media prefer UFPT or ICUI?

In the previous week, UFP Technologies had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for UFP Technologies and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.96 beat UFP Technologies' score of 0.78 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate UFPT or NVST?

Envista has a consensus target price of $29.31, indicating a potential upside of 7.71%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envista 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media refer more to UFPT or NVST?

In the previous week, UFP Technologies had 6 more articles in the media than Envista. MarketBeat recorded 13 mentions for UFP Technologies and 7 mentions for Envista. Envista's average media sentiment score of 1.09 beat UFP Technologies' score of 0.78 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NEOG or UFPT?

Neogen currently has a consensus target price of $11.67, indicating a potential downside of 2.37%. Given Neogen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Neogen is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is NEOG or UFPT more profitable?

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -0.91% 2.78% 1.74% UFP Technologies 11.45% 18.42% 11.96%

Does the media prefer NEOG or UFPT?

In the previous week, UFP Technologies had 11 more articles in the media than Neogen. MarketBeat recorded 13 mentions for UFP Technologies and 2 mentions for Neogen. Neogen's average media sentiment score of 0.88 beat UFP Technologies' score of 0.78 indicating that Neogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

UFP Technologies (UFPT) Competitors

$309.13 +4.88 (+1.60%)

As of 08/21/2026 04:00 PM Eastern

Compare

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

Should you buy UFP Technologies stock or one of its competitors? UFP Technologies's main competitors and comparable companies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), ICU Medical (ICUI), Envista (NVST), and Neogen (NEOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

UFP Technologies has a net margin of 11.45% compared to Bausch + Lomb's net margin of -3.21%. UFP Technologies' return on equity of 18.42% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-3.21%	4.14%	1.93%
UFP Technologies	11.45%	18.42%	11.96%

Bausch + Lomb currently has a consensus price target of $18.75, indicating a potential upside of 8.70%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, equities analysts clearly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, UFP Technologies had 13 more articles in the media than Bausch + Lomb. MarketBeat recorded 13 mentions for UFP Technologies and 0 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 0.78 beat Bausch + Lomb's score of 0.00 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Bausch + Lomb	Neutral
UFP Technologies	Positive

Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 1.5% of Bausch + Lomb shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

UFP Technologies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.21	-$360M	-$0.48	N/A
UFP Technologies	$602.80M	3.97	$68.31M	$9.28	33.31

Summary

UFP Technologies beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Merit Medical Systems presently has a consensus price target of $100.00, indicating a potential upside of 10.16%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has a net margin of 11.45% compared to Merit Medical Systems' net margin of 9.22%. UFP Technologies' return on equity of 18.42% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
UFP Technologies	11.45%	18.42%	11.96%

In the previous week, UFP Technologies had 3 more articles in the media than Merit Medical Systems. MarketBeat recorded 13 mentions for UFP Technologies and 10 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.99 beat UFP Technologies' score of 0.78 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.58	$128.49M	$2.42	37.51
UFP Technologies	$602.80M	3.97	$68.31M	$9.28	33.31

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Merit Medical Systems and UFP Technologies tied by winning 8 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

UFP Technologies (NASDAQ:UFPT) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 4.6% of UFP Technologies shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

ICU Medical has a consensus price target of $192.80, suggesting a potential upside of 5.45%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

UFP Technologies has a net margin of 11.45% compared to ICU Medical's net margin of 1.39%. UFP Technologies' return on equity of 18.42% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
ICU Medical	1.39%	7.91%	4.17%

In the previous week, UFP Technologies had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for UFP Technologies and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.96 beat UFP Technologies' score of 0.78 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has higher earnings, but lower revenue than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.97	$68.31M	$9.28	33.31
ICU Medical	$2.23B	2.05	$730K	$1.18	154.95

UFP Technologies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, ICU Medical has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Summary

UFP Technologies beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

UFP Technologies (NASDAQ:UFPT) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

In the previous week, UFP Technologies had 6 more articles in the media than Envista. MarketBeat recorded 13 mentions for UFP Technologies and 7 mentions for Envista. Envista's average media sentiment score of 1.09 beat UFP Technologies' score of 0.78 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.3% of UFP Technologies shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

UFP Technologies has a net margin of 11.45% compared to Envista's net margin of 3.33%. UFP Technologies' return on equity of 18.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Envista	3.33%	7.88%	4.33%

UFP Technologies has higher earnings, but lower revenue than Envista. UFP Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.97	$68.31M	$9.28	33.31
Envista	$2.72B	1.61	$47M	$0.58	46.91

Envista has a consensus target price of $29.31, indicating a potential upside of 7.71%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.50

UFP Technologies has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Summary

UFP Technologies beats Envista on 10 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Neogen?

Neogen (NASDAQ:NEOG) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

96.7% of Neogen shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 0.6% of Neogen shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Neogen currently has a consensus target price of $11.67, indicating a potential downside of 2.37%. Given Neogen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Neogen is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Neogen has a beta of 1.77, meaning that its share price is 77% more volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

In the previous week, UFP Technologies had 11 more articles in the media than Neogen. MarketBeat recorded 13 mentions for UFP Technologies and 2 mentions for Neogen. Neogen's average media sentiment score of 0.88 beat UFP Technologies' score of 0.78 indicating that Neogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has lower revenue, but higher earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	2.99	-$7.90M	-$0.03	N/A
UFP Technologies	$602.80M	3.97	$68.31M	$9.28	33.31

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-0.91%	2.78%	1.74%
UFP Technologies	11.45%	18.42%	11.96%

Summary

UFP Technologies beats Neogen on 9 of the 16 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.39B	$6.02B	$7.38B	$12.85B
Dividend Yield	N/A	1.74%	2.53%	10.78%
P/E Ratio	33.31	26.54	272.33	24.21
Price / Sales	3.97	71.61	623.29	95.85
Price / Cash	25.02	33.24	78.62	53.99
Price / Book	5.18	6.23	13.05	6.20
Net Income	$68.31M	$150.07M	$3.47B	$348.59M
7 Day Performance	-3.93%	0.69%	2.10%	0.08%
1 Month Performance	29.91%	8.07%	6.12%	2.91%
1 Year Performance	36.94%	7.67%	25.00%	17.19%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	2.3939 of 5 stars	$309.13 +1.6%	N/A	+40.8%	$2.39B	$602.80M	33.31	5,349
BLCO Bausch + Lomb	3.457 of 5 stars	$17.00 -0.3%	$18.75 +10.3%	+19.0%	$6.09B	$5.10B	N/A	13,000
MMSI Merit Medical Systems	3.4351 of 5 stars	$89.73 -1.1%	$100.00 +11.4%	+4.8%	$5.42B	$1.52B	37.08	7,500	Positive News Analyst Upgrade Analyst Revision
ICUI ICU Medical	2.9897 of 5 stars	$182.51 -0.3%	$192.80 +5.6%	+50.2%	$4.57B	$2.23B	154.67	13,000
NVST Envista	2.322 of 5 stars	$27.68 -1.4%	$29.31 +5.9%	+33.2%	$4.44B	$2.86B	47.72	12,000	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 8/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Is BLCO or UFPT more profitable?

Do analysts rate BLCO or UFPT?

Does the media refer more to BLCO or UFPT?

Which has more volatility & risk, BLCO or UFPT?

Do insiders and institutionals believe in BLCO or UFPT?

Which has preferable valuation and earnings, BLCO or UFPT?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Do analysts prefer MMSI or UFPT?

Is MMSI or UFPT more profitable?

Does the media favor MMSI or UFPT?

Which has more risk & volatility, MMSI or UFPT?

Which has preferable earnings & valuation, MMSI or UFPT?

Do institutionals & insiders have more ownership in MMSI or UFPT?

Summary

How does UFP Technologies compare to ICU Medical?

Do insiders and institutionals hold more shares of UFPT or ICUI?

Do analysts rate UFPT or ICUI?

Is UFPT or ICUI more profitable?

Does the media prefer UFPT or ICUI?

Which has higher valuation and earnings, UFPT or ICUI?

Which has more risk and volatility, UFPT or ICUI?

Summary

How does UFP Technologies compare to Envista?

Does the media refer more to UFPT or NVST?

Do institutionals & insiders have more ownership in UFPT or NVST?

Is UFPT or NVST more profitable?

Which has stronger earnings and valuation, UFPT or NVST?

Do analysts rate UFPT or NVST?

Which has more risk and volatility, UFPT or NVST?

Summary

How does UFP Technologies compare to Neogen?

Do insiders & institutionals believe in NEOG or UFPT?

Do analysts prefer NEOG or UFPT?

Which has more volatility & risk, NEOG or UFPT?

Does the media prefer NEOG or UFPT?

Which has better earnings and valuation, NEOG or UFPT?

Is NEOG or UFPT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools